Tetchy on Tekmira: Time to Short this RNAi Play?

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions.] Tekmira (TKMR) shares have surged in response to announced use of its anti-Ebola RNAi therapeutic. Despite this, share action has occurred in […]